In vivo assessment shows shape-dependent blood circulation and biodistribution in mice, suggesting design optimization for drug delivery.
Particles at the nanometric-micrometric interface hold promise by combining the drug-loading capacity of microparticles with the systemic benefits of nanoparticles. We assess the in vivo behaviour in mice via PET...
No takes yet. Share an insight, caveat, or question.
Grzelak et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: